CDRH’s Division of Cardiovascular Devices Starts 30-Day Notice Reviews
This article was originally published in The Gray Sheet
Executive Summary
The division officially began taking over reviews of 30-day manufacturing notices from the Office of Compliance Feb. 1 as part of a larger reorganization.